Cargando…
Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
In recent years, the studies on ovarian cancer have made great progress, but the morbidity and mortality of patients with ovarian cancer are still very high. Due to the lack of effective early screening and detecting tools, 70% of ovarian cancer patients are diagnosed at an advanced stage. The overa...
Autores principales: | Yu, Ming, Zhu, Yu, Teng, Lichen, Cui, Jialin, Su, Yajuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062166/ https://www.ncbi.nlm.nih.gov/pubmed/33936202 http://dx.doi.org/10.1155/2021/6627241 |
Ejemplares similares
-
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017) -
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019) -
Can circulating cell free DNA be a promising marker in ovarian cancer? – a genome-scale profiling study in a single institution
por: Zhou, Huimei, et al.
Publicado: (2023) -
The Promise of Circulating Tumor DNA in Head and Neck Cancer
por: Aulakh, Sukhkaran S., et al.
Publicado: (2022) -
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)